Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update 29 July
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call 22 July
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing's Syndrome 17 June
